| S.No | Department | Ongoing | Completed |
| 1. | Bio-Chemistry | Anti-cancer activity of Chaulmoogra oil and Shwetha Sarshapa churna in the treatment of epidermal carcinoma of skin in experimental mice | 1. A biochemical role of AYUSH-PTK, an Ayurvedic formulation against anti-tubercular drug induced hepatotoxicity in rats2. Anti-atherosclerotic activity of Hirdayarnava rasa on animal model3. Biochemical studies on Premna integrifolia Linn. In high fat diet induced atherosclerosis model rats4. 28 days repeated dose oral toxicity study in rats of Gomutra Haritaki5. Genomic and Proteomic Approach of Commonly used Bhasmas in the treatment of various Ailments in Ayurveda6. Anti-obesity activity of Navayasa Louha in experimental animals.7. Biochemical evaluation of anti-diabetic activity of Trisama –A classical Ayurvedic formulation in experimental rats |
| 2. | Chemistry | 1. Development of quality standards & SOP with markers-based analysis and shelf-life study of four medicinally important classical ayurvedic formulations2. Isolation of Marker Compounds and Development of Marker Compound Library from four Selected Ayurvedic Medicinal Plants (Kancanara, Asthisrnkhala, Puskara & Lajjalu)3. Phytochemical investigation of hydro-alcoholic extractives with different ratios of selected Kvatha formulations4. Pharmaceutical Development and Standards for Formulation AYUSH-64 (Duration: 03 year, 2021-2024)5. Development of Quality Standards, Estimation of Markers, and Shelf-Life Study of Kvatha Curna Formulations (Duration: 03 years) 2023-20266. Evaluation of Seasonal and Geographical Variation on Phytoconstituents/Marker Compounds in Selected Ayurvedic Medicinal Plants (Duration 02 years) 2023-2025.7. Comparative phytochemical evaluation of Ht.Wd. with small branches, leaf, and st.bark of common medicinal plants used in Ayurveda (Duration 02 years) 2024-2026.8. Nutritional profiling, Estimation of marker of Balya Drugs’’9. Development of Quality Standards of Selected Extra-Pharmacopoeial Drugs (AnuktaDravyas) used in Local Health Traditions collected from different regions of India.10. Development of Quality Standards, Estimation of Markers and Accelerated Shelf-Life Studies of Guducyadi, Caturbhadra and Amrtottara Kvatha Curna Formulations.11. Isolation of Markers Compound from Ayurvedic Plants and Development of Marker Compound Library | 1. Estimation of Calcium and Trace minerals in Sudhavarga drugs of Ayurveda.2. Formulation of Drug Master File and Dossier for important promising medicinal plant Emblica officinalis (Phyllanthaceae) based on leads from Ayurveda and contemporary research3. Pharmacognostical Evaluation of Medicinal plants cited in Ayurvedic Formulary of India Excluding the plants Mentioned in Ayurvedic Pharmacopoeia of India” Part-II” |
| 3. | Pharmacology | 1. Development of Drug Master file and Dossier on fruit of Emblica officinalis for promising medicinal plants based on leads for Ayurveda and contemporary research. Pharmacology part.2. Cardioprotective Effect of Pushkara Guggulu on Experimentally Induced Myocardial Infarction in Rats, instruments purchased, order placed for procurement of animals.3. Development of Madhuca longifolia (Flower) based food recipe (Product development) and its nutritional,toxicity, efficacy and bioavailability studies4. Toxicity profile of Tribhuvana Kirti Rasa in experimental animals.5. Acute and chronic (180 days) oral toxicity study of coded drug AYUSH RP6. Acute and Chronic (180 days) repeated dose oral toxicity study of Nimbatitkam7. Acute and 180-days repeated dose oral toxicity study of Ayush Balrakshak Lehyam | 1. Effect of Haritkadi yoga on middle cerebral artery occlusion ischemic-reperfusion injury and its safety in rats.2. Acute and 90 days repeated dose oral toxicity study of Coded drug AYUSH-PK Avaleha3. Acute and 90 days repeated dose oral toxicity study of Coded drug AYUSH-SDM.4. Evaluation of Sveta Parpati for its curative and preventive action in Urolithiasis experimental study in rats.5. Preclinical Evaluation (Toxicity and efficacy profile) of an Ayurvedic herbal formulation Vaisvanara Churna used in the treatment of Rheumatoid arthritis.6. Acute and 90 days repeated dose oral toxicity study of Coded drug AYUSH-HR7. Biochemical evaluation of the Anti-atherosclerotic activity of Premna integrifolia Linn. (Agnimantha) in experimental animal model.8. In vitro and in vivo nephro protective evaluation of AYUSH K1 extract. 9. In-vitro and in-vivo evaluation of anti-migraine activity of AYUSH-M3.10. Anti-atherosclerotic activity of Hridhayarnava Rasa against atherosclerosis in animal model.11. A Biochemical role of AYUSH-PTK an Ayurvedic formulation against Anti-tubercular drug induced Hepatotoxicity in Rats.12. Safety and anti-obesity activity of Tryusanadi guggulu in experimental animals. |
| 4. | Pharmacognosy/ Botany | 1. Development of Quality Standards for Useful Parts of Selected Medicinal Plants of Ayurveda.2. Development and Digitalization of Authentic Ayurvedic Raw Drugs and Herbarium for the Medicinal Plants Appearing in Ayurvedic Formularies of India in Mandatory Drug Testing Laboratories of CCRAS.3. Development of Quality Standards of Selected Extra-pharmacopoeial Drugs (Anukta Dravyas) Used in Local Health Traditions Collected from Different Regions of India. | 1. Pharmacognostic evaluation and assessment of antioxidant and anti-inflammatory responses of Ethno- Medicinal Plant Elsholtzia blanda in-vitro and in-vivo models.2. Photographic Atlas on Macro microscopic Characteristics of Medicinal Plants Listed in Ayurvedic Pharmacopoeia of India, Part-I, Volume – II.3. Development of Drug Master File and Dossier on Dried Mature Fruit Pulp of Phyllanthus emblica L. (Phyllanthaceae) for Important Promising Medicinal Plants Based on Leads from Ayurveda & Contemporary Research.4. Pharmacognostical Evaluation of Medicinal Plants Cited in Ayurvedic Formulary of India Excluding the Plants Mentioned in Ayurvedic Pharmacopoeia of India” Part II.5. Developing Pharmacognostical Standards for some Ambiguous Ayurvedic Drugs (Sandigdha Dravyas) Appearing in the Ayurvedic Formularies, Parts I to III.6. Anthology of Pharmacognostical Research Outcomes of CCRAS on Selected Medicinal Plants of Ayurveda |
| 5. | Pharmacy | 1. Development of quality standards for selected Arka formulations2. Documentation of Life-profiles of Admirable Personalities to Transform Ayurveda (APTA) | 1. Ethno-medicinal Survey of Plants used in various diseases by tribe of Thandarai, Chengalpattu, Kancheepuram District, Tamilnadu2. Documentation of Life Profiles of Luminaries in the field of Ayurveda3. Effect of Sodhana Procedures on Chemical Profiling of Ayurvedic Drugs of Plant Origin (Visa Dravya) mentioned under Schedule E -1 of Drugs & Cosmetics Act4. Development of Quality Standards of Indigenous Medicinal Plants and Preparation of Monographs There on5. Developing Quality Standards for selected Extra-pharmacopoeial Drugs collected from Irula Tribes of Thandarai, Kancheepuram District, Tamilnadu, |
| 6. | Microbiology | Isolation and Identification of Endophytic Microorganisms from the stem barks used in Ayurveda (Panchavalkala) and Evaluation of their Antimicrobial, antioxidant and antibiofilm activities | Antibacterial activity of selective Ayurveda formulations against Gastrointestinal infection, Respiratory infection and Urinary Tract infection causing bacteria |